China 2024 Outlook: Biotech To Feel Ongoing Chill Despite Dealmaking Cheer
Innovative Funding Methods Being Pursued
Biotech founders and executives in China are having to embrace continuing uncertainty around funding as the light at the end of the tunnel still appears a way off, but partnerships and alternative financing routes are providing some relief.
